Our study revealed that knocking down NUBP2 effectively inhibited EMT in CRC, while NUBP2 overexpression increased the expression of p-GSK-3β, p-AKT, p-PI3K, β-catenin and Cyclin D1. This evidence concerns the gene GSK3B and colorectal carcinoma.